BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND SDHB, PGL4, 6390, ENSG00000117118, SDH1, SDHIP, SDH, IP
186 results:

  • 1. The GFPT2-O-GlcNAcylation-YBX1 axis promotes IL-18 secretion to regulate the tumor immune microenvironment in pancreatic cancer.
    Zhang HR; Li TJ; Yu XJ; Liu C; Wu WD; Ye LY; Jin KZ
    Cell Death Dis; 2024 Apr; 15(4):244. PubMed ID: 38575607
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. EIF2Ss, a Novel c-Myc-Correlated Gene Family, is Associated with Poor Prognosis and Immune Infiltration in pancreatic Adenocarcinoma.
    Cao Z; Jing Y; Cheng C; Wang F; Guan M; Zhang K; Jiao J; Ruan L; Chen Z
    Front Biosci (Landmark Ed); 2024 Mar; 29(3):119. PubMed ID: 38538250
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. PELI1: key players in the oncogenic characteristics of pancreatic cancer.
    Fei X; Zhu C; Liu P; Liu S; Ren L; Lu R; Hou J; Gao Y; Wang X; Pan Y
    J Exp Clin Cancer Res; 2024 Mar; 43(1):91. PubMed ID: 38528516
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Acylcarnitines promote gallbladder cancer metastasis through lncBCL2L11-THOC5-JNK axis.
    Yang Y; Li H; Liu K; Zou L; Xiang S; Geng Y; Li X; Qiu S; Yang J; Cui X; Li L; Li Y; Li W; Yan S; Liu L; Wu X; Liu F; Wu W; Chen S; Liu Y
    J Transl Med; 2024 Mar; 22(1):299. PubMed ID: 38519939
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. SERPINE2 promotes liver cancer metastasis by inhibiting c-Cbl-mediated EGFR ubiquitination and degradation.
    Zhang S; Jia X; Dai H; Zhu X; Song W; Bian S; Wu H; Chen S; Tang Y; Chen J; Jin C; Zhou M; Xie H; Zheng S; Song P
    Cancer Commun (Lond); 2024 Mar; 44(3):384-407. PubMed ID: 38407942
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Role of endoscopic ultrasound-guided fine needle aspiration biopsies in diagnosing pancreatic neoplasms in the paediatric population: experience from a tertiary center and review of the literature.
    Radulovic MK; Brecelj J; Gruden A; Flezar MS
    Radiol Oncol; 2024 Mar; 58(1):78-86. PubMed ID: 38378032
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Downregulation of Roundabout guidance receptor 2 suppresses hepatocellular carcinoma progression by interacting with Y-box binding protein 1.
    Liu T; Zhai C; Tian B; Li C; Han S; Wang S; Xuan M; Liu D; Zhao Y; Zhao H; Yu W; Wang J
    Sci Rep; 2024 Jan; 14(1):2588. PubMed ID: 38297025
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Exosome-derived tRNA fragments tRF-GluCTC-0005 promotes pancreatic cancer liver metastasis by activating hepatic stellate cells.
    Chen W; Peng W; Wang R; Bai S; Cao M; Xiong S; Li Y; Yang Y; Liang J; Liu L; Yazdani HO; Zhao Y; Cheng B
    Cell Death Dis; 2024 Jan; 15(1):102. PubMed ID: 38291031
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. KIF20B and MET, hub genes of DIAPHs, predict poor prognosis and promote pancreatic cancer progression.
    Cao Z; Guan M; Cheng C; Wang F; Jing Y; Zhang K; Jiao J; Ruan L; Chen Z
    Pathol Res Pract; 2024 Feb; 254():155046. PubMed ID: 38266456
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Hypoxia upregulating ACSS2 enhances lipid metabolism reprogramming through HMGCS1 mediated PI3K/AKT/mTOR pathway to promote the progression of pancreatic neuroendocrine neoplasms.
    Gu D; Ye M; Zhu G; Bai J; Chen J; Yan L; Yu P; Lu F; Hu C; Zhong Y; Liu P; He Q; Tang Q
    J Transl Med; 2024 Jan; 22(1):93. PubMed ID: 38263056
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Interferon-Gamma-Inducible Protein 16 Inhibits Hepatocellular Carcinoma via Interferon Regulatory Factor 3 on Chemosensitivity.
    Lin W; Zhao Z; Du W; Ni Z; Pan C; Fang P; Li J; ZhuGe L; Jin S
    Dig Dis Sci; 2024 Feb; 69(2):491-501. PubMed ID: 38170337
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Elevated FBXL6 activates both wild-type KRAS and mutant KRAS
    Xiong HJ; Yu HQ; Zhang J; Fang L; Wu D; Lin XT; Xie CM
    Mil Med Res; 2023 Dec; 10(1):68. PubMed ID: 38124228
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Trends in access to minimally invasive pancreaticoduodenectomy for pancreatic cancers.
    Seldomridge AN; Rasic G; Papageorge MV; Ng SC; de Geus SWL; Woods AP; McAneny D; Tseng JF; Sachs TE
    HPB (Oxford); 2024 Mar; 26(3):333-343. PubMed ID: 38087704
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. hsa_circ_0007919 induces LIG1 transcription by binding to FOXA1/TET1 to enhance the DNA damage response and promote gemcitabine resistance in pancreatic ductal adenocarcinoma.
    Xu L; Ma X; Zhang X; Zhang C; Zhang Y; Gong S; Wu N; Zhang P; Feng X; Guo J; Zhao M; Ren Z; Zhang P
    Mol Cancer; 2023 Dec; 22(1):195. PubMed ID: 38044421
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. The gene RAD51AP1 promotes the progression of pancreatic cancer via the PI3K/Akt/NF-κB signaling pathway.
    Wang Y; Li Y; Ran C; Le W; Dong J; Wang X; Chen B; Jiang X
    Neoplasma; 2023 Dec; 70(6):722-732. PubMed ID: 37962862
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Alteration of the immunophenotype and cytokine profiles in patients affected by neuroendocrine neoplasms.
    Boemi I; Piccini S; Colombo FS; Smiroldo V; Zerbi A; Capretti G; Alloisio M; Trivellin G; Lavezzi E; Mazziotti G; Vitali E; Lania AG
    Endocrine; 2024 Mar; 83(3):810-823. PubMed ID: 37845576
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Constitutive photomorphogenic protein 1 ubiquitinates interleukin-1 receptor accessory protein in human liver cancer.
    Cao K; Liu Z; Liu J; Hu Q; Shan W; Hu B; Shi H; Zhang B
    J Cancer Res Clin Oncol; 2023 Dec; 149(18):16247-16260. PubMed ID: 37700160
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Targeting AHR Increases pancreatic cancer Cell Sensitivity to Gemcitabine through the ELAVL1-DCK Pathway.
    Stukas D; Jasukaitiene A; Bartkeviciene A; Matthews J; Maimets T; Teino I; Jaudzems K; Gulbinas A; Dambrauskas Z
    Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37685961
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Gemcitabine Inhibits the Progression of pancreatic cancer by Restraining the WTAP/MYC Chain in an m6A-Dependent Manner.
    Cao P; Zhang W; Qiu J; Tang Z; Xue X; Feng T
    Cancer Res Treat; 2024 Jan; 56(1):259-271. PubMed ID: 37591781
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. LncRNA SLC7A11-AS1 promotes the progression of hepatocellular carcinoma by mediating KLF9 ubiquitination.
    Zeng FL; Lin J; Xie X; Xie YK; Zhang JH; Xu D; He X; Liu FE; Xie BH
    Neoplasma; 2023 Jun; 70(3):361-374. PubMed ID: 37498069
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 10.